GenomeUp raised €1.1M in a Seed round in Feb 2022. The company is based in Rome, Italy. Investors in the round: a|impact, Finalca, GCM Group and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.